Fung Peter K 4

What Happened

• Peter K. Fung, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was granted a derivative award of 2,854 shares on June 30, 2026. The filing lists an acquisition price of $2.19 per share, for a nominal total value of $6,250. The transaction is reported as an award/grant (transaction code A) and is categorized as a derivative (not an open-market cash purchase).

Key Details

• Transaction date: 2026-06-30; filing date (Form 4): 2026-07-02.
• Price reported: $2.19 per share; total reported value: $6,250 (2,854 shares).
• Transaction type/code: Award/Grant (A); instrument classified as a derivative.
• Shares owned after the transaction: Not specified in the provided filing details.
• Timeliness: Filing was submitted within standard Form 4 timing (no late filing indicated).

Context

• This was an equity award (derivative grant), which typically reflects compensation or incentive arrangements rather than an open-market purchase or sale. The Form 4 does not specify the exact derivative instrument (e.g., RSUs vs. option settlement) or immediate disposition, so it does not indicate a bullish or bearish trading decision by the director.